Literature DB >> 19242587

A reader responds to "The myth of equipoise in phase 1 clinical trials".

John H Noble.   

Abstract

Mesh:

Year:  2008        PMID: 19242587      PMCID: PMC2644015     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN: 1934-1997


× No keyword cloud information.
  14 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

Review 2.  Subgroup analysis in clinical trials.

Authors:  David I Cook; Val J Gebski; Anthony C Keech
Journal:  Med J Aust       Date:  2004-03-15       Impact factor: 7.738

3.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

4.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

5.  The myth of equipoise in phase 1 clinical trials.

Authors:  Adil E Shamoo
Journal:  Medscape J Med       Date:  2008-11-05

Review 6.  Meta-analysis. Unresolved issues and future developments.

Authors:  G Davey Smith; M Egger
Journal:  BMJ       Date:  1998-01-17

7.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

8.  Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?

Authors:  Simon G Thompson; Julian P T Higgins
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

9.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

Authors:  S Yusuf; J Wittes; J Probstfield; H A Tyroler
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

10.  Underreporting research is scientific misconduct.

Authors:  I Chalmers
Journal:  JAMA       Date:  1990-03-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.